Evvy, the company focusing on closing the gender health gap through vaginal microbiome biomarkers, has expanded its flagship Vaginal Microbiome Test to include fertility insights. The new capabilities provide information on how the vaginal microbiome affects reproductive health.
The update addresses the connection between vaginal microbiome health and fertility outcomes, an area where research has shown significant correlations. According to the company, one-third of all infertility cases are diagnosed as “unexplained,” and vaginal microbial imbalances have been linked to infertility, recurrent pregnancy loss, and preterm birth.
“The connection between the vaginal microbiome and fertility is one of the most exciting frontiers in reproductive health,” said Dr. Kate McLean, Chief Medical Officer at Evvy. “We’ve seen compelling research linking specific vaginal bacteria to everything from embryo implantation to pregnancy loss — yet this crucial information wasn’t available to patients or providers in fertility care. By making these insights accessible, Evvy is bridging the gap between cutting-edge science and real-world clinical impact, giving individuals and providers a new tool to support reproductive success.”
The expanded test now includes a dedicated section for Fertility Insights with four key components:
- Protective Score: Measures levels of beneficial bacteria associated with positive outcomes. Higher levels of Lactobacillus, especially Lactobacillus crispatus, are linked to improved fertility, lower inflammation, and better pregnancy outcomes.
- Microbiome Diversity Score: Assesses overall microbiome diversity, as higher diversity has been connected to poorer IVF and pregnancy outcomes.
- Fertility Disruptors: Identifies bacteria specifically associated with negative fertility outcomes, including Fannyhessea, Gardnerella, and Prevotella.
- STI Testing (available as an add-on): Screens for sexually transmitted infections directly linked to infertility and pregnancy complications, with treatment accessible through Evvy’s platform if an STI is detected.
For each insight, Evvy provides information on where results fall within optimal ranges for fertility based on current research. The company also offers personalized prescription treatments, lifestyle recommendations, and one-on-one health coaching through its care protocols.
“For too long, fertility has been treated like a black box — leaving millions of people searching for answers with no clear path forward,” said Priyanka Jain, co-founder and CEO of Evvy. “By expanding our Vaginal Microbiome Test to include fertility insights, we’re giving people the power to take control of their reproductive health with comprehensive testing and data-driven, personalized care.”
